INTERNATIONAL PATENT: K-BIOCELF INC., (주)한국바이오셀프 FILES APPLICATION FOR "VACCINE COMPOSITION COMPRISING NOROVIRUS GII MRNA"

GENEVA, Aug. 19 -- K-BIOCELF INC. (5F, 503, 77 Changnyong-daero 256beon-gil, Yeongtong-guSuwon-siGyeonggi-do 16229), (주)한국바이오셀프 (경기도수원시영통구 창룡대로256번길 77, 5층 503호) filed a patent application (PCT/KR2025/001935) for "VACCINE COMPOSITION COMPRISING NOROVIRUS GII MRNA" on Feb 10, 2025. With publication no. WO/2025/170389, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO)....